Compass Therapeutics, Inc. (CMPX)
NASDAQ: CMPX · Real-Time Price · USD
2.200
-0.180 (-7.56%)
Jun 1, 2026, 11:03 AM EDT - Market open
Compass Therapeutics Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Canaccord Genuity | Canaccord Genuity | Buy Maintains $7 | Buy | Maintains | $7 | +218.18% | May 22, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $24 | Buy | Reiterates | $24 | +990.91% | May 22, 2026 |
| LifeSci Capital | LifeSci Capital | Buy Maintains $6 | Buy | Maintains | $6 | +172.73% | May 10, 2026 |
| Craig-Hallum | Craig-Hallum | Buy Maintains n/a | Buy | Maintains | n/a | n/a | May 7, 2026 |
Unknown Analyst Guggenheim No rating | Guggenheim | Buy Maintains $12 → $8 | Buy | Maintains | $12 → $8 | +263.64% | May 6, 2026 |
| William Blair | William Blair | Buy Maintains n/a | Buy | Maintains | n/a | n/a | May 5, 2026 |
| Raymond James | Raymond James | Hold Downgrades n/a | Hold | Downgrades | n/a | n/a | Apr 28, 2026 |
| Stifel Nicolaus | Stifel Nicolaus | Buy Maintains $12 → $6 | Buy | Maintains | $12 → $6 | +172.73% | Apr 27, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.